MAPK1 and RASopathy: To address this need, we generated the first mouse model of MRR to identify the physiological, anatomical, and neurodevelopmental sequelae of ERK2 gain-of-function in vivo and explore the role of downstream MAPK proteins in Rasopathy phenotypes.